Akebia Therapeutics (AKBA) Debt to Equity (2018 - 2026)
Akebia Therapeutics (AKBA) reported Debt to Equity of $1.79 for Q1 2026, down 5.61% year-over-year from $1.89 in Q1 2025, and up 20.7% quarter-over-quarter from $1.48 in Q4 2025.
Akebia Therapeutics (AKBA) Debt to Equity (2018 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has 9 years of Debt to Equity data on file, last reported at $1.79 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $1.79, down 5.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.79 (down 5.61% YoY), and the FY2025 annual result was $1.48, up 288.08% from the prior year.
- Debt to Equity rose to $1.79 in Q1 2026 per AKBA's latest filing, from $1.48 in the prior quarter.
- Over five years, Debt to Equity peaked at $12.63 in Q4 2022 and troughed at -$2.63 in Q1 2023.
- A 5-year average of $1.43 and a median of $1.15 in 2025 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2022 and 2023: Debt to Equity soared 1026.32% in 2022, then slumped 195.17% in 2023.
- A 5-year view of Debt to Equity shows it stood at $12.63 in 2022, then slumped by 108.98% to -$1.13 in 2023, then surged by 30.63% to -$0.79 in 2024, then jumped by 288.08% to $1.48 in 2025, then rose by 20.7% to $1.79 in 2026.
- Business Quant data shows AKBA's Debt to Equity at $1.79 in Q1 2026, $1.48 in Q4 2025, and $1.15 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | Akebia Therapeutics | 243.23 Mn | 80.63 Mn | 41.25 Mn | 1.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.79 |
| Dec 31, 2025 | 1.48 |
| Sep 30, 2025 | 1.15 |
| Jun 30, 2025 | 1.61 |
| Mar 31, 2025 | 1.89 |
| Dec 31, 2024 | -0.79 |
| Sep 30, 2024 | -0.76 |
| Jun 30, 2024 | -1.13 |
| Mar 31, 2024 | -1.11 |
| Dec 31, 2023 | -1.13 |
| Sep 30, 2023 | -1.08 |
| Jun 30, 2023 | -1.59 |
| Mar 31, 2023 | -2.63 |
| Dec 31, 2022 | 12.63 |
| Sep 30, 2022 | 7.98 |
| Jun 30, 2022 | 1.67 |
| Mar 31, 2022 | 4.33 |
| Dec 31, 2021 | 1.32 |
| Sep 30, 2021 | 0.71 |
| Jun 30, 2021 | 0.55 |